ScholarIQanswers from OpenAlex

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset

PaperCitations, authors & open-access status

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset have?

ScholarIQcitation count

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset has 141 citations in the OpenAlex counts ScholarIQ stores.

When was Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset published?

ScholarIQyear

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset has 2020 year in the ScholarIQ index.

What is the open-access status of Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset?

ScholarIQoa status

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset has bronze oa status in the ScholarIQ index.

What is the DOI of Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset?

ScholarIQdoi

The DOI for Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset is on the source record.

What is the PMID of Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset?

ScholarIQpmid

The PMID for Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset is on the source record.

What is the OpenAlex record for Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset?

ScholarIQopenalex

The OpenAlex for Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial